Transaction Will Accelerate Global Growth of Mobidiag’s Differentiated Molecular Platform, which Offers Ease of Use, Multiplex Capability and Rapid Turnaround…
The post Mobidiag to Be Acquired by Hologic, Innovator in Women’s Health Diagnostic Testing, for Approximately €668 Million appeared first on Mobidiag.
Mobidiag is a Finland-based biotechnology company that manufactures and commercialization of vaccine products for the prevention and treatment of infectious diseases.